Driving the growth of the European Science & Technology business with a focus on innovative growth sectors such as biotechnology, medical technology, food technology, green technology, specialty chemicals, aerospace, semiconductors, and advanced manufacturing. Initial priority markets include the DACH region, the Netherlands, the UK, Italy, France, Spain, and Central & Eastern Europe (CEE).Engagement opportunities span standing investments (asset/share acquisitions), (re)development projects, sale-and-leaseback transactions, and joint ventures.Investment focus: Core, Core+, and Value-Add strategies.Key Activities:✅ Strategic planning and development✅ Capital raising and structuring✅ Building strategic partnerships and joint ventures✅ Fund and investment management✅ Underwriting and financing strategies✅ Developing platforms and organizational structures✅ Business and brand growth initiatives✅ Driving thought leadership in the industry

Director within KPMG Strategy & Operations, part of the Global Strategy Group.Sample projects:✅ advising the CEO/CFO & CCO of an international listed hotel group on corporate strategy development ✅ advising the CEO of a private equity held residential developer on ESG strategy development✅ advising the global head of sustainability of an oil & gas company on net zero strategy development✅ advising global medical technology executives on the future of work, digitalisation and decarbonisation✅ advising a global pharmaceutical company on the future of work, digitalisation and decarbonisation ✅ an M&A target assessment for a Scandinavian hotel group to feed its Benelux expansion strategy.

Sample projects:✅ ABB Group - Technology & Robotics: global project lead role based in Zurich, leading a global team of 10 consultants (based in NL, Germany, Poland, Singapore and the US), supporting ABB with a global footprint optimization (1,500 locations) consisting of sales, production and logistics operations following a business spin-off and a cost savings program. Advising the global BU CFO's. ✅ Genmab - Biotechnology:Project lead to develop a global R&D location and workplace strategy, resulting in a state of the art global research center at the Utrecht Bioscience Park and best-in-class BSLI-II lab. Advised the CEO, CFO and COO. ✅ ABInBev - FMCG: EMEA Portfolio Strategy Lead to assess footprint , cost optimization and capital gain opportunities across the value chain, covering breweries, warehousing, offices and depots. The geographical scope among others consisted of the UK, Netherlands, Belgium, South-Africa and Russia.✅ Astellas Pharma - Biopharmaceutical:Global portfolio strategy covering over 300 locations in EMEA, North-America and Asia Pacific of which 80% of the footprint was located in Japan. Responsible for the identication of cost and footprint optimization thereby focusing on exit strategies, consolidation strategies, S&LB opportunities, etc. ✅ IFF - Speciality Chemicals:The EMEA and APAC (real estate) integration lead for the integration with DuPont Nutrition merger: https://ir.iff.com/news-releases/news-release-details/iff-complete-merger-duponts-nutrition-biosciences-business. Responsible for footprint optimization and cost synergies assessment across the value chain with the emphasis on sales/marketing and R&D.

Secondment role at Royal Philips, supporting the Global 🌏 M&A team with a diversity of merger, acquisition, divestment and post-merger integration projects for the Lighting and Healthcare business. Involvement in >50 global projects. M&A team member for the transformation from lighting / electronics to healthcare technology:My scope included:✅ strategy meetings with HR, IT, R&D, Environmental, Procurement and M&A Steerco✅ aligning the M&A and integration strategy with the footprint/supply chain of the NewCo ✅ location strategy development for HR, logistics, sales and manufacturing✅ synergies analysis, integration planning (300-days)✅ post-merger strategy implementation / program management

Secondment role at GSK Vaccines in Brussels & London supporting the 🌏 global acquisition and integration of Novartis Vaccines: https://www.gsk.com/en-gb/media/press-releases/gsk-completes-major-three-part-transaction-with-novartis/. 💊 My scope included:✅ Business strategy meetings (R&D, Manufacturing, Commercial, HR)✅ PMO day 1 planning, weekly updates, risk planning & mitigation✅ Data modelling & quality optimization✅ Integrated data modelling ✅ Portfolio/footprint planning - aligning the global site strategies to the business strategies✅ Day 1 implementation✅ Value capture analysis✅ Organisational design

✅ Military service of 2,5 years at the Royal Dutch Army. Infantry regiment with several foreign training expeditions and a 6-month stabilization mission to Bosnia Herzegovina for the redevelopment of Bugojno and Suica (post-War).